Excitement is building as a new treatment for advanced bladder cancer that doubles survival time has been approved for NHS ...

New trial results reveal enfortumab vedotin and pembrolizumab significantly improve survival for muscle-invasive bladder ...

Professor Peter Johnson, NHS England’s National Clinical Director for Cancer, said: “This is one of the most hopeful advances in decades for people with bladder cancer who will now be offered a ...

THOUSANDS of Brits with bladder cancer could survive for twice as long after a new treatment was given the green light to be ...

New trial results reveal that pembrolizumab and enfortumab vedotin significantly enhance survival rates for muscle-invasive ...

NICE has recommended a new first-line treatment for adults with advanced bladder cancer, marking a significant breakthrough for patients facing this devastating disease.

In this Phase III trial, the Padcev-Keytruda combination used as both neoadjuvant and adjuvant therapy significantly improved event-free and overall survival, as well as pathologic complete response, ...

New advanced bladder cancer treatment can ‘double chances of survival’ - Treatment for advanced bladder cancer had not ...

A new treatment for advanced bladder cancer that doubles life expectancy is set for use on the NHS. Experts said it was the most significant advancement in bladder cancer treatment since the 1980s.

Some 1200 patients a year in England are set to benefit from a “breakthrough” life extending treatment for bladder cancer after the National Institute for Health and Care Excellence (NICE) approved it ...

Around 18,000 people in England are diagnosed with bladder cancer each year, and experts hope the new treatment - a combination of two drugs - will help patients spend far more time with their loved ...